Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
Create a narrative
Our community narratives are driven by numbers and valuation.
Create a narrative
Weekly Picks
Alphabet
BL
BlackGoat
Community Contributor
Alphabet: The Under-appreciated Compounder Hiding in Plain Sight
Summary Google trades at ~18× forward earnings; the cheapest among the Magnificent 7 Market is too focused on AI threats to Search and antitrust noise Meanwhile, Google is executing across AI, Cloud, and YouTube Key AI differentiator: unmatched distribution across 3B+ users via Search, Gmail, YouTube, Android, Chrome, and Cloud Quietly building a world-class AI infrastructure behind the scenes; including proprietary TPUs and a vertically integrated stack YouTube generated $8.93B in Q1 ad revenue (up 10% YoY); subscriptions hit 270M Google Cloud revenue up 28% YoY to $12.3B; now profitable Optionality from long-term bets like Waymo, DeepMind, and Verily Risk/reward is compelling; a strong candidate to beat the market long term Overview Despite being part of the "Magnificent Seven," Google’s stock lags due to perceived risks around disruption of its Search business from AI competitors and mounting antitrust concerns. But under the hood, Google has quietly built one of the most compelling setups in tech: with deep AI leadership, multiple high-growth businesses, and optionality from long-term moonshots like Waymo.
View narrative
US$282.83
FV
32.8% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
21
users have liked this narrative
3
users have commented on this narrative
59
users have followed this narrative
Updated
narrative
Planet Labs PBC
AN
andreas_eliades
Community Contributor
Planet Labs: At The Heart Of The Emerging New Space Boom
Planet Labs leads the EO market with the largest satellite constellation, poised to capitalize on the growing demand for Earth Observation and geospatial data from companies and governments. Plunging space launch and GPU computation costs combined with advancements in CubeSat and AI technologies are boosting the utility of Earth Observation data.
View narrative
US$11.31
FV
45.4% undervalued
intrinsic discount
30.00%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
1
users have commented on this narrative
62
users have followed this narrative
New
narrative
Exxon Mobil
AG
Agricola
Community Contributor
Exxon in Guyana 5 year forecast Low $135 to High $189
Previous mistake rectified. So as pointed out in the comments, Chevron won the Hess bid (rather than Exxon) and took a large portion of the Stabroek block.
View narrative
US$174.00
FV
37.0% undervalued
intrinsic discount
12.97%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
4
users have commented on this narrative
16
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Community Investing Ideas
Load previous narratives
Inogen
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Yuwell Collaboration Will Open Chinese Respiratory Market
Key Takeaways Strategic partnerships and product innovation in China and digital health are expected to drive growth and improve earnings potential. Operational efficiencies and cost management are likely to enhance profitability and strengthen Inogen's balance sheet.
View narrative
US$11.67
FV
46.8% undervalued
intrinsic discount
5.74%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
3
users have commented on this narrative
5
users have followed this narrative
10 days ago
author updated this narrative
HomeToGo
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Interhome Acquisition And Eight Market Expansion Will Unlock Opportunity
Key Takeaways HomeToGo's strategic expansion into new markets and increased emphasis on direct bookings aim to enhance revenue and reduce marketing costs, boosting net margins. Investments in AI technology and strategic acquisitions are expected to drive revenue growth and strengthen EBITDA margins by improving operational efficiencies and brand recognition.
View narrative
€4.10
FV
62.2% undervalued
intrinsic discount
31.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
10 days ago
author updated this narrative
ITM Power
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
EU Renewable Hydrogen Demand Will Spur Electrolyzer Capacity Expansion
Key Takeaways EU hydrogen strategy could boost ITM's revenues due to increased demand for their technology as electrolyzer capacity expands. Operational improvements and strategic initiatives enhance margins, revenue growth, and competitiveness while preserving cash flow.
View narrative
UK£0.84
FV
28.3% undervalued
intrinsic discount
68.84%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
36
users have followed this narrative
10 days ago
author updated this narrative
Innoviz Technologies
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
LiDAR, Mobileye And NVIDIA Integration Will Unlock Future Markets
Key Takeaways Strategic partnerships and production expansion will bolster customer base and revenue potential through increased demand in autonomous vehicle platforms. Diversification efforts in non-automotive sectors may open new revenue opportunities, supporting long-term growth and financial stability.
View narrative
US$2.68
FV
44.7% undervalued
intrinsic discount
129.97%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
38
users have followed this narrative
10 days ago
author updated this narrative
Canopy Growth
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
New Medical Cannabis And Vaporizer Offerings Will Expand Global Markets
Key Takeaways Growth in the medical cannabis sector and product innovation in adult-use and premium vaporizers position Canopy for revenue and market share expansion. Acquisitions and operational efficiencies in the U.S. and international markets aim to drive profitability through cost synergies and improved net margins.
View narrative
CA$3.31
FV
55.9% undervalued
intrinsic discount
4.70%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
30
users have followed this narrative
10 days ago
author updated this narrative
Y-mAbs Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Pipeline Developments And Radiopharmaceutical Advances Will Extend Global Reach
Key Takeaways Stronger market adoption of DANYELZA and international expansion are expected to drive recurring revenue and broaden the patient base. Advancements in antibody engineering and rare oncology pipeline will support new product launches and profitable long-term growth.
View narrative
US$14.70
FV
69.2% undervalued
intrinsic discount
8.92%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
10 days ago
author updated this narrative
Synthomer
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Chemical Realignment And Adhesives Expansion Will Build A Resilient Future
Key Takeaways Shift to high-margin specialty chemicals and divestment of non-core operations are expected to enhance profitability. Expansion into specialty adhesives and sustainability initiatives aim to drive revenue and demand for value-added products.
View narrative
UK£1.71
FV
53.3% undervalued
intrinsic discount
3.19%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
10 days ago
author updated this narrative
Aquestive Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
FDA Approval And Anaphylm Launch Will Expand Global Reach
Key Takeaways Success in FDA approval for Anaphylm and Libervant expansion could significantly boost revenue and market penetration. Targeting international markets and developing new treatments offer potential revenue diversification and growth opportunities.
View narrative
US$8.42
FV
54.6% undervalued
intrinsic discount
27.67%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
10 days ago
author updated this narrative
Capricorn Energy
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Egypt Concessions And North Sea Assets Will Create Mixed Outcomes
Key Takeaways Extended concession agreements in Egypt could unlock reserves, improve production, and drive future revenue growth. Acquiring high-value assets in the U.K. North Sea without liabilities offers revenue diversification and incremental earnings opportunities.
View narrative
UK£3.31
FV
31.6% undervalued
intrinsic discount
0.94%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
10 days ago
author updated this narrative
Value any company in seconds
Popular companies